Big Apple Hospital CEOs are Cooking the Not-for-Profit Hospital Books

  • CMPI | by: Peter Pitts |
  • 03/23/2026 12:00 AM
Big Apple Hospital CEOs are Cooking the Not-for-Profit Hospital Books
There is something almost too neat—too polished—about the way not-for-profit hospitals
tell their financial story. It is a narrative carefully plated for public consumption: billions in
“community benefits,” selfless care for the underserved, and a moral justification for
billions more in tax exemptions. On paper, it looks like altruism at scale. In practice, it often
looks like creative accounting.

The latest analysis of New York City’s not-for-profit hospitals provides a perfect case study.
According to the report, these institutions delivered $9.5 billion in “community benefits” in
2023, rising to $11.3 billion when additional categories are included. Against roughly $2.2
billion in tax exemptions, the conclusion seems obvious: hospitals give far more than they
receive.

Case closed—right? Not quite.

Because what counts as a “community benefit” is less a measure of generosity than a
masterclass in definitional elasticity. And when you pair that elasticity with how these
same institutions compensate their leadership, the question becomes harder to ignore: are
we measuring charity—or just cooking the books?

READ FULL ARTICLE HERE.
 
Sign Up for Our Email Newsletter

RECENT NEWS

New JCI Viewpoint: FDA Must Rethink How It Evaluates Precision Medicines for Rare Diseases

New JCI Viewpoint: FDA Must Rethink How It Evaluates Precision Medicines for Rare Diseases

Authors argue that rare disease innovation requires learning more from fewer patients—not enrolling more patients...  Read more

Troubling Trends: Systemic Practices in Texas' Non-Profit Hospitals That Inflate Health Care Costs

Troubling Trends: Systemic Practices in Texas' Non-Profit Hospitals That Inflate Health Care Costs

Texas has an opportunity to lead rather than react. Better measurement would strengthen public confidence without diminis...  Read more

PROTECTING THE U.S. PHARMACEUTICAL SUPPLY CHAIN: A PATH FORWARD

PROTECTING THE U.S. PHARMACEUTICAL SUPPLY CHAIN: A PATH FORWARD

How proactive FDA policies can help strengthen the American pharmaceutical supply chain of essential medicines, create jo...  Read more

DRUGWONKS BLOG